Your browser is no longer supported. Please, upgrade your browser.
Settings
BIOS BioScrip, Inc. daily Stock Chart
BIOS [NASD]
BioScrip, Inc.
Index- P/E- EPS (ttm)-0.93 Insider Own0.71% Shs Outstand128.36M Perf Week-0.80%
Market Cap476.22M Forward P/E- EPS next Y-0.21 Insider Trans0.00% Shs Float127.14M Perf Month-6.78%
Income-118.00M PEG- EPS next Q-0.03 Inst Own82.20% Short Float7.27% Perf Quarter35.40%
Sales707.90M P/S0.67 EPS this Y-136.10% Inst Trans-0.53% Short Ratio9.65 Perf Half Y23.26%
Book/sh-0.99 P/B- EPS next Y44.70% ROA-8.60% Target Price5.57 Perf Year23.67%
Cash/sh0.15 P/C25.20 EPS next 5Y10.00% ROE46.90% 52W Range2.31 - 4.14 Perf YTD3.92%
Dividend- P/FCF- EPS past 5Y-39.20% ROI-19.80% 52W High-10.39% Beta0.76
Dividend %- Quick Ratio1.60 Sales past 5Y6.60% Gross Margin35.20% 52W Low60.95% ATR0.19
Employees1727 Current Ratio1.80 Sales Q/Q-8.90% Oper. Margin1.50% RSI (14)53.24 Volatility4.92% 5.24%
OptionableYes Debt/Eq- EPS Q/Q29.90% Profit Margin-7.10% Rel Volume0.66 Prev Close3.81
ShortableYes LT Debt/Eq- EarningsFeb 05 BMO Payout- Avg Volume957.89K Price3.71
Recom1.40 SMA201.37% SMA505.36% SMA20024.67% Volume634,057 Change-2.62%
Aug-10-17Upgrade SunTrust Hold → Buy
Mar-06-17Reiterated Barrington Research Outperform $1.50 → $2.25
Jan-03-17Initiated Lake Street Buy $4.50
Nov-08-16Resumed Jefferies Buy
Aug-12-15Reiterated Dougherty & Company Buy $7 → $4
Aug-11-15Downgrade Sun Trust Rbsn Humphrey Buy → Neutral
Feb-04-14Reiterated Dougherty & Company Buy $8 → $12
Nov-08-13Downgrade Feltl & Co. Strong Buy → Buy $11 → $7.50
Sep-25-13Reiterated Dougherty & Company Buy $15 → $10
Jun-18-13Reiterated Dougherty & Company Buy $15 → $20
Jun-17-13Reiterated Feltl & Co. Strong Buy $17 → $20
Apr-09-13Initiated Feltl & Co. Strong Buy $15
May-10-12Reiterated Dougherty & Company Buy $10 → $13
Sep-28-11Initiated BB&T Capital Mkts Buy $10
Aug-04-09Upgrade Piper Jaffray Neutral → Overweight
Sep-12-08Downgrade Piper Jaffray Buy → Neutral
Aug-13-08Initiated Noble Financial Buy $6.50
May-06-08Reiterated Broadpoint Capital Buy $9 → $6
Apr-30-08Reiterated Dougherty & Company Buy $15 → $8
Feb-15-08Upgrade Broadpoint Capital Neutral → Buy $9
Jan-03-19 09:00AM  BioScrip to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-18-18 02:55AM  Here is What Hedge Funds Think About BioScrip Inc. (BIOS) Insider Monkey
Dec-06-18 09:30AM  Why Is BioScrip (BIOS) Up 18.7% Since Last Earnings Report? Zacks
Nov-28-18 11:50AM  Biomedical Trends Fuel New Momentum For Healthcare Stocks; Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI), Alliqua BioMedical, BioScrip, Coremedix ACCESSWIRE
Nov-26-18 04:30PM  BioScrip to Host Analyst and Investor Day GlobeNewswire +14.55%
12:55PM  4 Healthcare Stocks Seeing New Highs On Monday ACCESSWIRE
Nov-20-18 09:00AM  BioScrip to Present at the Bank of America Merrill Lynch 2018 Leveraged Finance Conference GlobeNewswire
Nov-16-18 10:50AM  4 Healthcare Stocks Turning Toward Tech For New Growth ACCESSWIRE
Nov-09-18 10:18AM  BioScrip (BIOS) Q3 Loss Wider Than Expected, Revenues Beat Zacks
Nov-07-18 09:30PM  Edited Transcript of BIOS earnings conference call or presentation 6-Nov-18 2:00pm GMT Thomson Reuters StreetEvents
Nov-06-18 09:40AM  BioScrip (BIOS) Reports Q3 Loss, Tops Revenue Estimates Zacks +14.23%
08:37AM  BioScrip: 3Q Earnings Snapshot Associated Press
08:00AM  BioScrip Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-01-18 08:00AM  BioScrip Comments on Implementation of Medicare Home Infusion Transition Benefit GlobeNewswire
Oct-25-18 09:00AM  BioScrip to Present at the 2018 Stephens NY Investment Conference GlobeNewswire
08:25AM  Factors of Influence in 2018, Key Indicators and Opportunity within Portola Pharmaceuticals, Cable One, Marriot Vacations Worldwide, United Technologies, Park-Ohio, and BioScrip New Research Emphasizes Economic Growth GlobeNewswire
Oct-24-18 09:00AM  BioScrip Schedules Release of Third Quarter 2018 Financial Results and Conference Call GlobeNewswire -5.76%
Oct-22-18 04:30PM  BioScrip Appoints John McMahon as Chief Accounting Officer GlobeNewswire
Oct-10-18 10:29AM  BioScrip Grows on CORE Plan, Reimbursement Issues Persist Zacks
Sep-06-18 10:17AM  BioScrip (BIOS) Up 4.8% Since Last Earnings Report: Can It Continue? Zacks
Sep-05-18 09:00AM  BioScrip to Participate in Upcoming Investor Conferences GlobeNewswire
07:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Aerie Pharmaceuticals, BioScrip, Celsion, Primoris Services, Cyclacel Pharmaceuticals, and Barnes Group New Research Emphasizes Economic Growth GlobeNewswire
Aug-16-18 11:45PM  Edited Transcript of BIOS earnings conference call or presentation 7-Aug-18 1:00pm GMT Thomson Reuters StreetEvents
08:25AM  Factors of Influence in 2018, Key Indicators and Opportunity within BioScrip, Powell Industries, Portola Pharmaceuticals, Daktronics, Cable One, and Park-Ohio New Research Emphasizes Economic Growth GlobeNewswire
Aug-08-18 10:25AM  BioScrip (BIOS) Q2 Loss Wider Than Expected, Revenues Top Zacks
Aug-07-18 09:25AM  BioScrip (BIOS) Reports Q2 Loss, Tops Revenue Estimates Zacks
08:22AM  BioScrip: 2Q Earnings Snapshot Associated Press
08:00AM  BioScrip Reports Second Quarter 2018 Financial Results GlobeNewswire
07:00AM  BioScrip, Inc. to Host Earnings Call ACCESSWIRE
Jul-30-18 05:06PM  BioScrip, Inc. -- Moody's upgrades BioScrip's CFR to Caa1; outlook stable Moody's
03:31PM  5 Stocks In Bearish Trends This Week Benzinga
08:30AM  BioScrip Appoints Leslie McIntosh as Chief Human Resources Officer GlobeNewswire
Jul-23-18 04:30PM  BioScrip to Present at the 38th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-19-18 07:50AM  Initiating Free Research Reports on Horizon Pharma and Three Other Healthcare Equities ACCESSWIRE
Jul-18-18 04:30PM  BioScrip Schedules Release of Second Quarter 2018 Financial Results and Conference Call GlobeNewswire
Jul-13-18 07:26AM  Moving Average Crossover Alert: BioScrip (BIOS) Zacks
Jul-12-18 10:24AM  Here's Why You Should Invest in BioScrip (BIOS) Right Now Zacks
Jul-10-18 08:30AM  BioScrip Appoints Richard Denness as Chief Commercial Officer GlobeNewswire
Jul-05-18 09:19AM  Outpatient Market Gains on Social Awareness: 3 Stocks in Focus Zacks
Jun-11-18 06:12AM  Why Is BioScrip (BIOS) Down 2% Since its Last Earnings Report? Zacks
May-30-18 07:00AM  Free Daily Technical Summary Reports on CVS Health and Three Other Healthcare Stocks ACCESSWIRE +6.37%
May-28-18 04:02PM  Edited Transcript of BIOS earnings conference call or presentation 10-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-16-18 09:00AM  BioScrip to Participate in Upcoming Investor Conferences GlobeNewswire
May-11-18 09:11AM  BioScrip (BIOS) Q1 Loss Wider Than Expected, Revenues Beat Zacks
May-10-18 09:24AM  BioScrip: 1Q Earnings Snapshot Associated Press
08:30AM  BioScrip Reports First Quarter 2018 Financial Results GlobeNewswire
May-03-18 08:15AM  Report: Developing Opportunities within Boston Private Financial, Ares Management, BioScrip, Glacier, CBIZ, and Powell Industries Future Expectations, Projections Moving into 2018 GlobeNewswire
Apr-26-18 04:30PM  BioScrip Schedules Release of First Quarter 2018 Financial Results and Conference Call GlobeNewswire
Apr-10-18 05:03PM  BioScrip Incs (NASDAQ:BIOS) Earnings Dropped -62.14%, Did Its Industry Show Weakness Too? Simply Wall St.
Apr-09-18 04:07AM  Why Is BioScrip (BIOS) Down 5.6% Since its Last Earnings Report? Zacks
Apr-04-18 07:20AM  Blog Exposure - Addus Homecare Completes Acquisition of Arcadia Home Care & Staffing for $18.5 Million ACCESSWIRE
Mar-26-18 06:30AM  BioScrip Timely Files Annual Form 10-K, Concludes Accounting Review and Provides Update on Immaterial Financial Statement Corrections GlobeNewswire +6.10%
Mar-21-18 08:20AM  New Research Coverage Highlights Real Goods Solar, LivePerson, Manhattan Associates, Natus Medical, BioScrip, and FBL Financial Group -- Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-20-18 03:09PM  Lifshitz & Miller LLP Announces Investigation of BioScrip, Inc., Civitas Solutions, Inc., Iridex Corp., OHR Pharmaceutical, Inc., Overstock.com, Inc., Syneos Health, Inc., Ubiquiti Networks, Inc. and WageWorks, Inc. PR Newswire
Mar-19-18 12:46PM  What does BioScrip Incs (NASDAQ:BIOS) Balance Sheet Tell Us About Its Future? Simply Wall St.
Mar-16-18 10:50AM  BioScrip's Dull 2017 Earnings a Woe, Core Business Robust Zacks
Mar-15-18 05:30PM  BioScrip Provides Update on Annual Form 10-K Filing Status Business Wire
Mar-14-18 02:58PM  Catalyst Pharmaceuticals Inc (CPRX) and Achillion Pharmaceuticals, Inc. (ACHN) Among Five Cheap Healthcare Stocks To Buy Now Insider Monkey
01:37PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of BioScrip, Inc. -- BIOS Business Wire
08:44AM  Why BioScrip (BIOS) Could Be Positioned for a Slump Zacks
Mar-12-18 10:57AM  BioScrip (BIOS) Loss Widens in Q4, '18 View Holds Promise Zacks
Mar-10-18 06:11AM  Edited Transcript of BIOS earnings conference call or presentation 8-Mar-18 2:00pm GMT Thomson Reuters StreetEvents
Mar-09-18 02:30PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of BioScrip, Inc. Investors Business Wire
Mar-08-18 06:27PM  Milberg Tadler Phillips Grossman LLP Announces Investigation of BioScrip, Inc. PR Newswire -15.47%
05:15PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of BioScrip, Inc. Business Wire
04:00PM  BIOSCRIP INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In BioScrip Inc. To Contact The Firm PR Newswire
03:48PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioScrip, Inc. - BIOS PR Newswire
02:05PM  BioScrip, Inc. (BIOS) Investigated By Block & Leviton LLP For Violations Of The Federal Securities Laws PR Newswire
10:17AM  BioScrip reports 4Q loss Associated Press
08:33AM  BioScrip accounting review identifies 'internal control deficiencies' and 'material weakness' MarketWatch
08:00AM  BioScrip Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
07:30AM  BioScrip, Inc. to Host Earnings Call ACCESSWIRE
Feb-23-18 05:33PM  A Look At The Fair Value Of BioScrip Inc (NASDAQ:BIOS) Simply Wall St.
Feb-22-18 08:00AM  BioScrip Schedules Release of Fourth Quarter and Full Year 2017 Financial Results and Conference Call Business Wire
Feb-09-18 07:30AM  BioScrip Announces U.S. Congress Passage of Medicare Home Infusion Transition Benefit, Effective 2019 Business Wire
Jan-30-18 08:01PM  One Thing To Consider Before Buying BioScrip Inc (NASDAQ:BIOS) Simply Wall St.
Jan-19-18 11:55AM  What Can We Expect for BioScrip Inc (NASDAQ:BIOS) Moving Forward? Simply Wall St.
08:10AM  Analysis: Positioning to Benefit within BioScrip, LPL Financial, Jagged Peak Energy, Standex International, FBL Financial Group, and Nathan's Famous Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jan-08-18 08:00AM  BioScrip Announces Availability of HEMLIBRA® for Hemophilia Patients GlobeNewswire
Dec-29-17 01:15PM  BioScrip Inc (NASDAQ:BIOS): Does 8.3% Earnings Drop In A Year Reflect The Long-Term Trend? Simply Wall St.
Dec-28-17 11:52AM  ETFs with exposure to BioScrip, Inc. : December 28, 2017 Capital Cube
Dec-14-17 10:45AM  Have Investors Already Priced In BioScrip Incs (NASDAQ:BIOS) Growth? Simply Wall St.
Dec-11-17 01:35PM  ETFs with exposure to BioScrip, Inc. : December 11, 2017 Capital Cube
Nov-30-17 01:33PM  ETFs with exposure to BioScrip, Inc. : November 30, 2017 Capital Cube
08:00AM  BioScrip to Host Meetings at the Mizuho Investor Conference GlobeNewswire
Nov-28-17 08:00AM  BioScrip Announces Additions to Senior Leadership Team GlobeNewswire
Nov-22-17 07:28AM  BioScrip, Inc. breached its 50 day moving average in a Bullish Manner : BIOS-US : November 22, 2017 Capital Cube
Nov-20-17 11:50AM  ETFs with exposure to BioScrip, Inc. : November 20, 2017 Capital Cube
Nov-17-17 07:54AM  What does BioScrip Incs (BIOS) Balance Sheet Tell Us Abouts Its Future? Simply Wall St.
Nov-16-17 09:00AM  BioScrip to Present at Bank of America Merrill Lynch 2017 Leveraged Finance Conference GlobeNewswire +6.07%
Nov-09-17 12:07PM  ETFs with exposure to BioScrip, Inc. : November 9, 2017 Capital Cube
08:00AM  BioScrip to Host Meetings at the 8th Annual Craig-Hallum Alpha Select Conference GlobeNewswire
Nov-07-17 07:57AM  BioScrip, Inc. :BIOS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube
Nov-03-17 10:42AM  BioScrip (BIOS) Q3 Loss Wider Than Expected, Revenues Miss Zacks +8.38%
Nov-02-17 05:51PM  Edited Transcript of BIOS earnings conference call or presentation 2-Nov-17 1:00pm GMT Thomson Reuters StreetEvents -20.42%
10:22AM  Is BioScrip Inc (BIOS) Expensive For A Reason? A Look At The Intrinsic Value Simply Wall St.
09:23AM  BioScrip reports 3Q loss Associated Press
08:00AM  BioScrip Reports Third Quarter 2017 Financial Results GlobeNewswire
07:40AM  BioScrip, Inc. to Host Earnings Call ACCESSWIRE
Oct-31-17 08:00AM  BioScrip to Present at Stephens Fall Investment Conference GlobeNewswire
BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient's homes, outpatient clinics, nursing facilities, physician's offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coliseum Capital Management, LDirectorMay 02Option Exercise0.0049,66901,938,660May 04 05:58 PM